Cite
MLA Citation
P. Nash et al.. “THU0448 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Adalimumab Up To 48 Weeks Using A Matching-Adjusted Indirect Comparison.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 353–354. http://access.bl.uk/ark:/81055/vdc_100135129078.0x000053